Dapagliflozin Propanediol 5mg tablet |
Company |
Formulation ID |
FDA Description |
Astrazeneca Ab
|
F23957
|
Microcrystalline Cellulose; Anhydrous Lactose; Crospovidone; Silicon Dioxide; Magnesium Stearate; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol; Talc; Yellow Iron Oxide |
------------------------------------------------------------------------------------ |
|
|
|
Dapagliflozin Propanediol 10mg tablet |
Company |
Formulation ID |
FDA Description |
Astrazeneca Ab
|
F23958
|
Microcrystalline Cellulose; Anhydrous Lactose; Crospovidone; Silicon Dioxide; Magnesium Stearate; Polyvinyl Alcohol; Titanium Dioxide; Polyethylene Glycol; Talc; Yellow Iron Oxide |
------------------------------------------------------------------------------------ |
|
|
|
Dapagliflozin 10 mg tablet |
Company |
Formulation ID |
FDA Description |
E.R. Squibb & Sons
|
F05226
|
Anhydrous lactose; Magnesium stearate; Crospovidone; Silicon dioxide; Cellulose, microcrystalline |
AstraZeneca
|
F05225
|
Anhydrous lactose; Magnesium stearate; Silicon dioxide; Cellulose, microcrystalline; Crospovidone (15 mpa.s at 5%) |
------------------------------------------------------------------------------------ |
|
|
|
Dapagliflozin 5 mg tablet |
Company |
Formulation ID |
FDA Description |
E.R. Squibb & Sons
|
F05228
|
Anhydrous lactose; Magnesium stearate; Crospovidone; Silicon dioxide; Cellulose, microcrystalline |
AstraZeneca
|
F05227
|
Anhydrous lactose; Magnesium stearate; Silicon dioxide; Cellulose, microcrystalline; Crospovidone (15 mpa.s at 5%) |
------------------------------------------------------------------------------------ |
|
|
|